KPV – 500MCG CAPSULES (60 COUNT)

Description

DESCRIPTION

KPV is a synthetic tripeptide fragment (Lys-Pro-Val) derived from the C-terminal sequence of α-MSH (alpha-melanocyte-stimulating hormone). It is studied in research models for activity at MC1R receptor pathways and associated inflammatory signaling.

RESEARCH AREAS

• Inflammatory cytokine research — studied in cell-based assays for effects on IL-6, TNF-α, and IL-1β pathways.
• Epithelial barrier research — investigated in wound-healing models for effects on gut lining and epithelial integrity.
• MC1R receptor pathway research — characterized for receptor binding activity distinct from full-length α-MSH.
• Immune signaling research — explored in innate immune pathway models for cytokine modulation activity.

WHAT RESEARCHERS LOOK AT

• MC1R receptor binding profile compared to full-length α-MSH.
• Effects on inflammatory cytokines (IL-6, TNF-α, IL-1β) in cell-based assays.
• Epithelial barrier and wound-healing model outcomes.
• Comparative research alongside related α-MSH fragment peptides.

QUICK SPECS

• Form: Capsules
• Net per capsule: 500 mcg
• Quantity: 50 capsules
• Purity: ≥99% (HPLC)
• Identity: MS-verified (per COA)
• Storage: Cool, dry place; avoid heat and moisture

IDENTITY BASICS

• Type: Synthetic tripeptide α-MSH fragment
• Sequence: Lys-Pro-Val
• Molecular weight: ~369.46 g/mol
• CAS: 162045-99-4

SELECTED RESEARCH

• Anti-inflammatory effects of α-MSH fragments: https://pubmed.ncbi.nlm.nih.gov/10998324/
• KPV in epithelial wound healing: https://pubmed.ncbi.nlm.nih.gov/19433895/
• Immune modulation and cytokine suppression: https://pubmed.ncbi.nlm.nih.gov/12197815/

⚠️ DISCLAIMER

• • This product is intended for laboratory research use only.

• Not for human or veterinary use.
• Not approved for diagnostic, therapeutic, or medical applications.
• Handle using appropriate laboratory safety procedures and personal protective equipment.